Cargando…

Primary prevention of cardiovascular disease events with renin-angiotensin system blockade in autosomal dominant polycystic kidney disease dialysis patients: A nationwide cohort study

Although renin-angiotensin system (RAS) blockade has been shown to reduce cardiovascular disease (CVD) in the general population and high-risk subjects, their protective effect in autosomal dominant polycystic kidney disease (ADPKD) patients under dialysis was still unknown. By using the database fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Chien-Lin, Lin, Chien-Yu, Lin, Lian-Yu, Chen, Pau-Chung, Zheng, Cai-Mei, Lu, Kuo-Cheng, Yeih, Dong-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257834/ https://www.ncbi.nlm.nih.gov/pubmed/34190195 http://dx.doi.org/10.1097/MD.0000000000026559

Ejemplares similares

Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease
por: Lai, Silvia, et al.
Publicado: (2016)

Autosomal dominant polycystic kidney disease combined with hypertrophic cardiomyopathy: A case report
por: Shen, Yingjing, et al.
Publicado: (2017)

Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
por: Sans, Laia, et al.
Publicado: (2016)

Comprehensive analysis of mutations of renal cell carcinoma in an autosomal dominant polycystic kidney disease patient
por: Shim, Kwang Eon, et al.
Publicado: (2020)

Efficacy and safety of dual vs single renin–angiotensin–aldosterone system blockade in chronic kidney disease: An updated meta-analysis of randomized controlled trials
por: Zhao, Mingming, et al.
Publicado: (2021)

Clinical characteristics and risk factors for kidney failure in patients with autosomal dominant polycystic kidney disease: A retrospective study
por: Park, Hanil, et al.
Publicado: (2022)

New-onset Atrial Fibrillation is Associated With Polycystic Kidney Disease: A Nationwide Population-based Cohort Study
por: Yu, Tung-Min, et al.
Publicado: (2016)

Fatal outcome of autosomal recessive polycystic kidney disease in neonates with recessive PKHD1 mutations
por: Jung, Jiwon, et al.
Publicado: (2020)

Renin-angiotensin-aldosterone system blockers in Bulgarian COVID-19 patients with or without chronic kidney disease
por: Filev, Rumen, et al.
Publicado: (2022)

Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
por: Brosnahan, Godela M., et al.
Publicado: (2018)

Obstructive jaundice in a patient with polycystic liver disease complicated with polycystic kidney and polycystic lung: A case report
por: Zhang, Liling, et al.
Publicado: (2020)

Different Risk of Common Gastrointestinal Disease Between Groups Undergoing Hemodialysis or Peritoneal Dialysis or With Non-End Stage Renal Disease: A Nationwide Population-Based Cohort Study
por: Lee, Yi-Che, et al.
Publicado: (2015)

Effect of intrarenal renin-angiotensin-aldosterone system on renal function in patients after cardiac surgery
por: Niu, Peiyuan, et al.
Publicado: (2022)

Hemodialysis Is Associated With Increased Peripheral Artery Occlusive Disease Risk Among Patients With End-Stage Renal Disease: A Nationwide Population-Based Cohort Study
por: Lin, Chin-Sheng, et al.
Publicado: (2015)

Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study
por: Chang, Yu-Kang, et al.
Publicado: (2015)

Renoprotective effects of renin–angiotensin system inhibitor combined with calcium channel blocker or diuretic in hypertensive patients: A PRISMA-compliant meta-analysis
por: Cheng, Yiming, et al.
Publicado: (2016)

Clinical burden of autosomal dominant polycystic kidney disease
por: Hung, Peir-Haur, et al.
Publicado: (2020)

Effects of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on all-cause mortality, cardiovascular death, and cardiovascular events among peritoneal dialysis patients: A protocol for systematic review
por: Nochaiwong, Surapon, et al.
Publicado: (2020)

Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes: Results From a Nationwide Prospective Cohort in Korea
por: Lee, Mi Jung, et al.
Publicado: (2016)

Combined renin-angiotensin-aldosterone system blockade and statin therapy effectively reduces the risk of cerebrovascular accident in autosomal dominant polycystic kidney disease: a nationwide population-based cohort study
por: Sung, Pei-Hsun, et al.
Publicado: (2017)

Left Ventricular Diastolic Dysfunction in Peritoneal Dialysis: A Forgotten Risk Factor
por: Wu, Cho-Kai, et al.
Publicado: (2015)

Association Between Chronic Osteomyelitis and Risk of End-Stage Renal Disease: A Nationwide Population-Based Cohort Study
por: Lin, Shih-Yi, et al.
Publicado: (2015)

Association Between Blood Cadmium Levels and Mortality in Peritoneal Dialysis
por: Lee, Cheng-Chia, et al.
Publicado: (2016)

Risk Factors Associated with End-Stage Renal Disease (ESRD) in Patients With Atherosclerotic Renal Artery Stenosis: A Nationwide Population-Based Analysis
por: Yu, Tung-Min, et al.
Publicado: (2015)

Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease
por: Chang, Po-Ya, et al.
Publicado: (2015)

Nonapnea Sleep Disorders and the Risk of Acute Kidney Injury: A Nationwide Population-Based Study
por: Lin, Hugo You-Hsien, et al.
Publicado: (2016)

Vesicoureteral reflux is associated with increased risk of chronic kidney disease: A nationwide cohort study
por: Lee, Suat Yee, et al.
Publicado: (2023)

Alteration and association between serum ACE2/ angiotensin(1-7)/Mas axis and oxidative stress in chronic kidney disease: A pilot study
por: Shi, Chengqian, et al.
Publicado: (2020)

Risk factors of gender for renal progression in patients with early chronic kidney disease
por: Chang, Po-Ya, et al.
Publicado: (2016)

A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease
por: Chen, Yi-Chun, et al.
Publicado: (2015)

Peritoneal Dialysis is Associated With A Better Survival in Cirrhotic Patients With Chronic Kidney Disease
por: Chou, Che-Yi, et al.
Publicado: (2016)

Association between macular degeneration and mild to moderate chronic kidney disease: A nationwide population-based study
por: Chen, Chun-Yu, et al.
Publicado: (2017)

Environmental NO(2) Level is Associated with 2-Year Mortality in Patients Undergoing Peritoneal Dialysis
por: Lin, Jui-Hsiang, et al.
Publicado: (2015)

A nationwide survey of clinical characteristics, management, and outcomes of acute kidney injury (AKI) – patients with and without preexisting chronic kidney disease have different prognoses
por: Pan, Heng-Chih, et al.
Publicado: (2016)

A Comparison of Uremic Pruritus in Patients Receiving Peritoneal Dialysis and Hemodialysis
por: Wu, Hon-Yen, et al.
Publicado: (2016)

Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study
por: Chiu, Ping-Fang, et al.
Publicado: (2016)

Low-site versus traditional peritoneal dialysis catheterization: A meta-analysis
por: Gong, Lifeng, et al.
Publicado: (2020)

Impact of Environmental Particulate Matter and Peritoneal Dialysis-related Infection in Patients Undergoing Peritoneal Dialysis
por: Huang, Wen-Hung, et al.
Publicado: (2014)

Hip fractures in elderly patients with non-dialysis dependent chronic kidney disease: Outcomes in a Southeast Asian population
por: Roy, Debajyoti, et al.
Publicado: (2021)

Febuxostat-induced agranulocytosis in an end-stage renal disease patient: A case report
por: Poh, Xue Er, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eg15njpi0qa0prclv0d7d21ugd